Episode Details
Back to Episodes
Episode 35: Biotech's October slump, the precise cost of precision, and breaking postpartum silence
Published 7 years, 11 months ago
Description
Why are biotech stocks in the dumps? Is the latest in cancer care overhyped? And what does "folie à deux" mean?